FinanceCity
DiversifiedNSE · BSE

INNOVA CAPTAB LIMITED

INNOVACAP · ISIN INE0DUT01020

Share price

₹965 +1.83%

Market capitalisation

₹5524 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹5524 Cr

Current price

₹965

+1.83% today

52W high

₹978

52W low

₹622

Stock P/E

39.16

P/B ratio

5.06

02 · Per share & returns

EPS (TTM)

₹24.65

Book value

₹191

ROE

13.75%

ROA

6.83%

Dividend yield

0.42%

Beta

0.01

03 · Financials (TTM)

By the numbers

Revenue

₹1630 Cr

+42.30% YoY

EBITDA

₹231 Cr

Net profit

₹141 Cr

+28.60% YoY

Profit margin

8.64%

Operating margin

9.55%

Total debt

₹344 Cr

Total cash

₹68.25 Cr

Debt / equity

0.32x

Current ratio

1.87x

Payout ratio

8.12%

04 · Analyst view

Target price

₹1,079

Upside

+11.73%

Consensus

NONE

Analysts

2

05 · Shareholding pattern

Who owns INNOVACAP?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
INNOVACAP
Exchange
NSE · BSE
CIN
ISIN
INE0DUT01020
BSE code
544067
Sector
Diversified
Industry
Face value
₹10
Listing date
28 Dec 2023
Employees
Headquarters
Panchkula, India

07 · About

What is INNOVA CAPTAB LIMITED?

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

08 · Common questions

Frequently asked

What is the CIN of INNOVA CAPTAB LIMITED?+

The Corporate Identity Number for INNOVA CAPTAB LIMITED is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of INNOVA CAPTAB LIMITED?+

Promoter and group-holding details for INNOVA CAPTAB LIMITED are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of INNOVA CAPTAB LIMITED?+

INNOVA CAPTAB LIMITED (INNOVACAP) has a market capitalisation of approximately ₹5524 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other diversified listings

Full sector →